Highlights AroCell AB

Equities

AROC

SE0003883990

Delayed Nasdaq Stockholm Other stock markets 08:00:02 15/05/2024 BST			5-day change	1st Jan Change
0.395 ^SEK	-5.50%		-3.91%	-4.35%

05-03	AroCell AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-18	Swedish Diagnostics Company AroCell Secures US Patent	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AroCell AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-03	CI
Swedish Diagnostics Company AroCell Secures US Patent	04-18	MT
AroCell AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-22	CI
AroCell AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-22	CI
AroCell Wins Regulatory Nod for Typhoid Fever Rapid Test in Ethiopia	01-25	MT
AroCell AB Obtains Regulatory Approval for TUBEX® TF in Ethiopia	01-25	CI
AroCell AB Announces Results of Serum Tk1 Protein Levels Can Predict the Survival of Patients with Metastatic Prostate Cancer Patients	01-15	CI
AroCell AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-02	CI
AroCell AB Announces New Study Highlights the Clinical Significance of TK1 SA for Early Detection of Ovarian Cancer	18/09/23	CI
AroCell AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23/08/23	CI
AroCell AB Signs Additional Agreement with ZECEN Biotech Co., Ltd	17/07/23	CI
AroCell AB Reports Earnings Results for the First Quarter Ended March 31, 2023	03/05/23	CI
AroCell AB Announces TK1 together with PSA can predict more than 10 years differences in survival in men with prostate cancer	09/03/23	CI
Arocell AB Announces Improved Early Detection of Ovarian Cancer with Dual Biomarker Algorithm	06/03/23	CI
AroCell AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23/02/23	CI
AroCell Signs Distribution Agreement in Ethiopia	01/02/23	CI
AroCell AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	27/10/22	CI
AroCell Signs Distribution Agreement with MM African Technology Covering Zambia and Malawi	19/10/22	CI
AroCell To Register TPS CLIA Tumor Marker In Chinese Market	06/09/22	MT
AroCell AB Expands Its Presence in the Chinese Market	06/09/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AroCell AB

Equities

AROC

SE0003883990

Highlights

Filters